Cargando…

Alternative approaches to target Myc for cancer treatment

The Myc proto-oncogene family consists of three members, C-MYC, MYCN, and MYCL, which encodes the transcription factor c-Myc (hereafter Myc), N-Myc, and L-Myc, respectively. Myc protein orchestrates diverse physiological processes, including cell proliferation, differentiation, survival, and apoptos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chen, Zhang, Jiawei, Yin, Jie, Gan, Yichao, Xu, Senlin, Gu, Ying, Huang, Wendong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946937/ https://www.ncbi.nlm.nih.gov/pubmed/33692331 http://dx.doi.org/10.1038/s41392-021-00500-y

Ejemplares similares

Targeting MYC and BCL2 by a natural compound for “double‐hit” lymphoma
por: Liu, Xiaoqian, et al.
Publicado: (2022)

Therapeutic Approaches Targeting MYC-Driven Prostate Cancer
por: Rebello, Richard J., et al.
Publicado: (2017)

Inhibition of the CDK2 and Cyclin A complex leads to autophagic degradation of CDK2 in cancer cells
por: Zhang, Jiawei, et al.
Publicado: (2022)

Targeting oncogenic Myc as a strategy for cancer treatment
por: Chen, Hui, et al.
Publicado: (2018)

Strategically targeting MYC in cancer
por: Posternak, Valeriya, et al.
Publicado: (2016)

Identification of a novel RNA giant nuclear body in cancer cells
por: Zhou, Hong, et al.
Publicado: (2015)

Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma
por: Li, Shu, et al.
Publicado: (2021)

Targeting MYC Dependence by Metabolic Inhibitors in Cancer
por: Sabnis, Himalee S., et al.
Publicado: (2017)

Rationale for MYC imaging and targeting in pancreatic cancer
por: Schneider, Günter, et al.
Publicado: (2021)

Target c-Myc to treat pancreatic cancer
por: Ala, Moein
Publicado: (2022)

Small-molecule induction of phospho-eIF4E sumoylation and degradation via targeting its phosphorylated serine 209 residue
por: Gu, Ying, et al.
Publicado: (2015)

Therapeutic targeting of “undruggable” MYC
por: Llombart, Victor, et al.
Publicado: (2021)

Targeting MYC for triple-negative breast cancer treatment
por: Klauber-DeMore, Nancy, et al.
Publicado: (2018)

Succinate-Directed Approaches for Warburg Effect-Targeted Cancer Management, an Alternative to Current Treatments?
por: Casas-Benito, Adrian, et al.
Publicado: (2023)

Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
por: Allen-Petersen, Brittany L., et al.
Publicado: (2019)

G-Quadruplexes in c-MYC Promoter as Targets for Cancer Therapy
por: Bahls, Bárbara, et al.
Publicado: (2023)

Alternative Splicing as a Target for Cancer Treatment
por: Martinez-Montiel, Nancy, et al.
Publicado: (2018)

Small Molecules Targeting c-Myc Oncogene: Promising Anti-Cancer Therapeutics
por: Chen, Bing-Jia, et al.
Publicado: (2014)

Therapeutic Applications of Targeted Alternative Splicing to Cancer Treatment
por: Lin, Jung-Chun
Publicado: (2017)

Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer
por: Lee, Hwa-Yong, et al.
Publicado: (2020)

Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting
por: Pothuraju, Ramesh, et al.
Publicado: (2018)

Identification of the novel Np17 oncogene in human leukemia
por: Wu, Bowen, et al.
Publicado: (2020)

MYC in Brain Development and Cancer
por: Zaytseva, Olga, et al.
Publicado: (2020)

Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers
por: Vízkeleti, Laura, et al.
Publicado: (2023)

Alternative c-MYC mRNA Transcripts as an Additional Tool for c-Myc2 and c-MycS Production in BL60 Tumors
por: Ibrahim, Dina, et al.
Publicado: (2022)

Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer
por: Cargill, Kasey R., et al.
Publicado: (2021)

Plant Derived Bioactive Compounds, Their Anti-Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview
por: Shrihastini, Vijayakumar, et al.
Publicado: (2021)

Modeling and Targeting MYC Genes in Childhood Brain Tumors
por: Hutter, Sonja, et al.
Publicado: (2017)

The Molecular ‘Myc-anisms’ Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
por: McAnulty, Jessica, et al.
Publicado: (2020)

Alternative Psychotherapeutic Approaches to the Treatment of Eczema
por: Oska, Caroline, et al.
Publicado: (2022)

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc
por: Madden, Sarah K., et al.
Publicado: (2021)

A Brief Review on Chemoresistance; Targeting Cancer Stem Cells as an Alternative Approach
por: Toledo, Belén, et al.
Publicado: (2023)

The MYC Paralog-PARP1 Axis as a Potential Therapeutic Target in MYC Paralog-Activated Small Cell Lung Cancer
por: Bian, Xing, et al.
Publicado: (2020)

Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
por: Carabet, Lavinia A., et al.
Publicado: (2018)

MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975
por: Tang, Minhong, et al.
Publicado: (2022)

A Selective Small‐Molecule c‐Myc Degrader Potently Regresses Lethal c‐Myc Overexpressing Tumors
por: Xu, Ying, et al.
Publicado: (2022)

MYC Deregulation in Primary Human Cancers
por: Kalkat, Manpreet, et al.
Publicado: (2017)

MYC Ran Up the Clock: The Complex Interplay between MYC and the Molecular Circadian Clock in Cancer
por: Burchett, Jamison B., et al.
Publicado: (2021)

MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma
por: Wang, Lifu, et al.
Publicado: (2020)

Recent Advances and Future Prospects on the Tailing Covering Technology for Oxidation Prevention of Sulfide Tailings
por: Si, Meiyan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7ob0osiktae6hkjdooju4s742r